Adjuvant immunotherapy with high-dose ipilimumab has led to improvements in overall survival, whereas therapy with nivolumab and pembrolizumab has improved relapse-free survival with greater safety. Furthermore, adjuvant-targeted therapy with dabrafenib and trametinib has improved survival outcomes in BRAFV...
Stunning advances in gene research and data mining will predict diseases and devise treatments tailored to each of us.
Pembrolizumab vs. nivolumab: How do they compare? How does Nexavar work? Is it a chemo drug? How are Inlyta and Keytruda used in kidney cancer? How much does Afinitor cost per month? What is the success rate of Cabometyx (cabozantinib)? What is the difference between Mvasi and Avastin?
As NK/T lymphoma cells undergo apoptosis, EBV DNA fragments are released into the circulation [36]. Quantification of circulating EBV DNA provides a molecular measure of tumour load [37]. Whole blood is unsuitable and should not be used, because of unpredictable errors introduced by circulating m...
(3) how much do pathologists trust and accept AI? and (4) what is the best practical scoring scheme for PD-L1 expression in breast cancer? What is AI’s role in PD-L1 expression assessment? Human pathologists are not good at precisely evaluating ratios, especially when hundreds of cells ...
Recent review articles can also be very helpful in keeping updated in a particular area without devoting as much time as it takes to read every new clinical research article. Each of the major journals in oncology and hematology publishes serial reviews of current hot topics in the field. For...
“Metastatic castration-resistant prostate cancer is the most advanced and aggressive stage of the disease, and the TALAPRO-2 results provide much-needed hope to patients who remain in high unmet need of effective treatment options.” PT886 and Pembrolizumab Trial Commences for Gastric and GEJ ...
Unlike core protein, there is not much-known function of NS3, but it is known to interact with p53 and inactivate it [80]. NS5A interacts with growth factor receptor-bound protein 2, p53, p21, and cyclins and helps in the inhibition of the apoptosis [81]. It inactivates tumor ...
Pembrolizumab is just a small part of the rapidly expanding category of cancer treatments called immunotherapy. Scientists have spent years studying how the immune system fights infection and disease, and now they have found ways to build on some of those tools to fight cancer. Cancerous tumors ...
Pembrolizumab (Keytruda) This medicine is a checkpoint inhibitor used for high-risk, early-stage, triple-negative breast cancer (TNBC). It's done along with chemotherapy. It can also be given to treat metastatic TNBC when the tumor makes PD-L1 protein. ...